Flexsus selects GenXys software to help with pharmaceutical manufacturing data

VANCOUVER — GenXys Health Care Systems, Inc., a company involved in software with embedded pharmacogenetic data, recently finalized another customer deal to advance precision medicine initiatives with Ohio-based Flexsus, the laboratory division of FlexHealth.

Combined with GenXys’ precision prescribing platform, Flexsus can now reportedly perform pharmacogenomic (PGx) testing and report results that identify medication that may be most efficacious for individuals based upon their genomic profile, with the goal of enhancing patient wellness.

GenXys’ software with embedded pharmacogenetics will reportedly ensure differentiated PGx solutions for the Flexsus networked pharmacists. GenXys will overlay its expertise with the delivery of a connection and securitized data flow between Laboratory Information Management Systems, electronic health records, and other systems.

“As North America’s powerhouse support tool for precision prescribing, we are proud of the number of PGx profiles our software processes,” says Karl Pringle, CEO of GenXys. “Being a cloud-based solution means all our customers are conforming to the latest clinical and pharmacogenetic guidelines set by CPIC, FDA, and other industry groups. Providing evidence-based prescribing support with real-time PGx assessment and inclusion is becoming a must-have, not a nice-to-have. Through the integration with Flexsus, we’re also able to include existing medication history into the clinical decision support process and enable providers to use PGx data automatically at the point of care.”

GenXys also announced that they are expanding their U.S.-focused delivery team of professionals with the recent addition of David Wolfe, an established leader at the intersection of pharmacogenomics, clinical care, pharmacy informatics, and hospital pharmacy computer systems.